Lianbio
LIANY
$0.20
$0.0052.56%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.09% | 7.14% | -5.91% | 32.89% | 83.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.14% | -41.95% | -8.61% | 32.71% | 81.25% |
| Operating Income | -7.14% | 41.95% | 8.61% | -32.71% | -81.25% |
| Income Before Tax | -7.14% | 49.46% | 14.84% | 16.21% | -62.05% |
| Income Tax Expenses | 9,666.67% | 3,900.00% | 7,200.00% | 66.18% | 101.51% |
| Earnings from Continuing Operations | -9.78% | 49.00% | 13.28% | 13.77% | -67.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.78% | 49.00% | 13.28% | 13.77% | -67.00% |
| EBIT | -7.14% | 41.95% | 8.61% | -32.71% | -81.25% |
| EBITDA | -7.03% | 42.54% | 8.89% | -32.76% | -81.07% |
| EPS Basic | -10.98% | 48.63% | 13.19% | 39.81% | 68.11% |
| Normalized Basic EPS | -8.31% | 49.12% | 14.74% | 38.04% | 69.05% |
| EPS Diluted | -10.98% | 48.63% | 13.19% | 39.81% | 68.11% |
| Normalized Diluted EPS | -8.31% | 49.12% | 14.74% | 38.04% | 69.05% |
| Average Basic Shares Outstanding | -1.09% | -0.70% | -0.11% | 43.25% | 423.68% |
| Average Diluted Shares Outstanding | -1.09% | -0.70% | -0.11% | 43.25% | 423.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |